All In Biotech

Free tool

FAERS Monitor: Xiaflex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125338 or its brand name (Xiaflex, Collagenase Clostridium Histolyticum). Reports on generic versions are filed under their own applications.

Reports

5,433

Serious

1,380

25% of reports

Hospitalization

247

Death reported

61

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,359
  • contusion671
  • swelling576
  • pain506
  • penile swelling479
  • fracture of penis465
  • penile contusion449
  • injection site pain322
  • penile pain311
  • inappropriate schedule of product administration214
  • injection site swelling213
  • condition aggravated208
  • penile haematoma204
  • peyronie^s disease204
  • corpora cavernosa surgery197

Reports by year received

View as table
YearReports
201033
2011153
201251
201320
201443
2015361
2016422
2017332
2018418
2019656
2020742
2021589
2022530
2023303
2024324
2025304
2026152

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,726 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
corpora cavernosa surgerySignal197152644.962860.6740,556
penile contusionSignal44957984.440106.01,626,935
fracture of penisSignal46529056.822322.51,586,089
penile haematomaSignal20425495.017489.3682,680
penile swellingSignal4792487.62224.8723,585
penile painSignal311440.4392.8122,045
contusionSignal67127.225.316,842
swellingSignal57624.022.212,633
injection site swellingSignal21310.89.51,884
inappropriate schedule of product administrationSignal2144.64.0604
injection site painSignal3224.13.7752
drug ineffectiveSignal1,3594.03.83,249
painSignal5063.22.9781
condition aggravatedSignal2082.62.3215
peyronie^s disease2040.00.0786,481

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.